Development of fluorophoric and bivalent ligands at OP receptors: mobility and dynamics studies Primary Supervision: Michael Decker Secondary Supervisor: Davide Calebiro Lab webpage: http: www.pharmazie.uni-wuerzburg.de - Antagonist - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2014-05-13 11:14:11 Pharmacology Receptors Opioid receptor Ligand Receptor antagonist Receptor Agonist Biology Cell biology Cell signaling		Development of fluorophoric and bivalent ligands at OP receptors: mobility and dynamics studies Primary Supervision: Michael Decker Secondary Supervisor: Davide Calebiro Lab webpage: http://www.pharmazie.uni-wuerzburg.de Add to Reading List Source URL: www.graduateschools.uni-wuerzburg.de Download Document from Source Website File Size: 280,63 KB Share Document on Facebook

	Cortisol Stress Response in Men and Women Modulated Differentially by the Mu-Opioid Receptor Gene Polymorphism OPRM1 A118G DocID: 1up1j - View Document
	Variation in the ␮-opioid receptor gene (OPRM1) is associated with dispositional and neural sensitivity to social rejection Baldwin M. Way, Shelley E. Taylor, and Naomi I. Eisenberger1 Department of Psychology, Univers DocID: 1rCTQ - View Document
	Published on WebAsymmetric Synthesis of Salvinorin A, A Potent K Opioid Receptor Agonist Jonathan R. Scheerer, Jonathan F. Lawrence, Grace C. Wang, and David A. Evans* Department of Chemistry and Chemical Bi DocID: 1rohR - View Document
	HIGHLIGHTS OF PRESCRIBING INFORMATION • Do not abruptly discontinue BELBUCA in a physically dependent patient. These highlights do not include all the information needed to use BELBUCA safely and effectively. See full DocID: 1qmfz - View Document
	Call your doctor if you are elderly, unwell or you could buy lithosun canada have increased hunger or if you. A flawed judgment can put your overall health in danger and open up the dosage and right after consulting your DocID: 1pFHp - View Document